Moderna Inc (MRNA) — Cash Flow Reinvestment Rate
Moderna Inc (MRNA) has a Cash Flow Reinvestment Rate of 0.05x as of December 2025, reinvesting $48.00 Million (capex $39.00 Million plus investments $-9.00 Million) from operating cash flow of $951.00 Million. See MRNA free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Moderna Inc Cash Flow Reinvestment Rate (2016–2022)
Historical reinvestment intensity for Moderna Inc across 4 annual periods. For the full cash flow conversion analysis, see MRNA cash flow conversion.
Annual Cash Flow Reinvestment Rate for Moderna Inc (2016–2022)
Year-by-year capital reinvestment analysis for Moderna Inc. See MRNA financial flexibility score to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2022 | 1.12x | $5.58 Billion | $4.98 Billion | $400.00 Million | ▲ +78.9% |
| 2021 | 0.63x | $8.52 Billion | $13.62 Billion | $284.00 Million | ▼ -24.1% |
| 2020 | 0.82x | $1.67 Billion | $2.03 Billion | $67.45 Million | ▼ -91.9% |
| 2016 | 10.22x | $681.75 Million | $66.73 Million | $33.14 Million | — |